Literature DB >> 20549409

Nosocomial infections and fever of unknown origin in pediatric hematology/oncology unit: a retrospective annual study.

Youssef A Al-Tonbary1, Othman E Soliman, Mohammed M Sarhan, Moustafa A Hegazi, Rasha A El-Ashry, Ashraf A El-Sharkawy, Osama S Salama, Raida Yahya.   

Abstract

BACKGROUND: pediatric hematology/oncology patients are faced with an increased risk of nosocomial infections (NIs) that vary in different populations and different institutions with considerable morbidity and mortality. This study was undertaken to assess the frequency and patterns of NIs in 1564 pediatric patients and to determine the prevalence of causative organisms and their antimicrobial sensitivity.
METHODS: a retrospective analysis was made in the patients admitted between January 2007 and January 2008 to the pediatric hematoloy/oncology unit of Mansoura University, Egypt. The 1564 patients showed 2084 admissions and 27 092 inpatient days. The Centers for Disease Control and Prevention criteria were used as a standard definition for NI.
RESULTS: the overall rate of NIs in all patients and neutropenic patients was 8.6 and 25.3 per 1000 patient-days respectively. The frequent sites of NIs were blood stream (42.7%), the respiratory system (25.3%), the urinary system (22.2%) and the central nervous system (9.8%), whereas nosocomial fever of unknown origin constituted 52.9% of cases. The incidence of NIs was significantly higher during neutropenic days (P<0.001). Gram-positive organisms represented 64.5% of pathogens (Staphylococci 71.5%, Streptococci 16%, and pneumococci 7%), and Gram-negative organisms represented 30% (E. coli 48.6%, Klebsiella 15.7%, Pseudomonas 35.7%, and C. albicans 5.5%). Positive cultures were more frequent in summer (July to September). Susceptibility of isolated organisms was relatively low (cefoperazone/sulbactam 49.9%, amikacin 35.9%, imipenem/cilastin 34.4%, cefoperazone 33.6%, and vancomycin 36.5%). Methicillin-resistant S. aureus, extended spectrum beta lactamase and vancomycin resistant enterococci represented 30%, 45% and 75% of isolated S. aureus, Gram-negative organisms and Enterococci, respectively.
CONCLUSIONS: blood stream infection and fever of unknown origin are the most common nosocomial infections in pediatric hematology/oncology patients with a higher risk during neutropenic days. Isolated organisms are multi-drug resistant, predominantly Gram-positive pathogens with a high incidence of methicillin-resistant S. aureus, extended spectrum beta lactamase and vancomycin resistant enterococci organisms.

Entities:  

Mesh:

Year:  2010        PMID: 20549409     DOI: 10.1007/s12519-010-0212-1

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  36 in total

1.  Experience of vancomycin-resistant enterococci in a children's hospital.

Authors:  J W Gray; R H George
Journal:  J Hosp Infect       Date:  2000-05       Impact factor: 3.926

2.  National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998.

Authors: 
Journal:  Am J Infect Control       Date:  1998-10       Impact factor: 2.918

3.  Nosocomial infections in an oncology intensive care unit.

Authors:  E Velasco; L C Thuler; C A Martins; L M Dias; V M Gonçalves
Journal:  Am J Infect Control       Date:  1997-12       Impact factor: 2.918

4.  Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer.

Authors:  T Lehrnbecher; A Stanescu; J Kühl
Journal:  Infection       Date:  2002-01       Impact factor: 3.553

5.  Nosocomial infections in neutropenic cancer patients.

Authors:  P S Carlisle; R Gucalp; P H Wiernik
Journal:  Infect Control Hosp Epidemiol       Date:  1993-06       Impact factor: 3.254

6.  [Prevalence and antimicrobial susceptibility patterns of microorganisms causing bacteremia and fungemia in pediatric oncology patients].

Authors:  M L Cheguirián; L R Carvajal; E M Ledesma; M C Enrico; A L Reale; C Culasso; L Bertoni
Journal:  Rev Argent Microbiol       Date:  2008 Apr-Jun       Impact factor: 1.852

7.  Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus.

Authors:  J W Froggatt; J L Johnston; D W Galetto; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

Review 8.  Vancomycin resistance in staphylococci.

Authors:  Arjun Srinivasan; James D Dick; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  Vancomycin-resistant-enterococci--colonization of 24 patients on a pediatric oncology unit.

Authors:  F Schuster; U B Graubner; I Schmid; M Weiss; B H Belohradsky
Journal:  Klin Padiatr       Date:  1998 Jul-Aug       Impact factor: 1.349

10.  Central nervous system infection in the pediatric population.

Authors:  Rabi Narayan Sahu; Raj Kumar; A K Mahapatra
Journal:  J Pediatr Neurosci       Date:  2009-01
View more
  9 in total

1.  [Fever of unknown origin. Infectious causes].

Authors:  B Salzberger; A Schneidewind; F Hanses; G Birkenfeld; M Müller-Schilling
Journal:  Internist (Berl)       Date:  2012-12       Impact factor: 0.743

2.  KPC-producer gram negative bacteria among burned infants in Motahari Hospital, Tehran: first report from Iran.

Authors:  L Azimi; A Rastegar Lari; R Alaghehbandan; F Alinejad; M Mohammadpoor; M Rahbar
Journal:  Ann Burns Fire Disasters       Date:  2012-06-30

3.  Vancomycin-resistant enteroccus faecium and enterococcus faecalis isolated from education hospital of iran.

Authors:  Hossein Samadi Kafil; Mohammad Asgharzadeh
Journal:  Maedica (Buchar)       Date:  2014-12

4.  Emergence of Vancomycin-resistant Enterococci at a Teaching Hospital, Saudi Arabia.

Authors:  Fawzia E Alotaibi; Elham E Bukhari
Journal:  Chin Med J (Engl)       Date:  2017-02-05       Impact factor: 2.628

5.  Vancomycin-Resistant Enterococci and Its Associated Risk Factors among HIV-Positive and -Negative Clients Attending Dessie Referral Hospital, Northeast Ethiopia.

Authors:  Seid Ali; Martha Alemayehu; Mulat Dagnew; Teklay Gebrecherkos
Journal:  Int J Microbiol       Date:  2018-07-18

6.  Incidence of hospital-acquired pneumonia, bacteraemia and urinary tract infections in patients with haematological malignancies, 2004-2010: a surveillance-based study.

Authors:  Catherine Huoi; Philippe Vanhems; Marie-Christine Nicolle; Mauricette Michallet; Thomas Bénet
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

7.  Prevalence of vancomycin resistant Enterococci and associated risk factors among clients with and without HIV in Northwest Ethiopia: a cross-sectional study.

Authors:  Wondwossen Abebe; Mengistu Endris; Moges Tiruneh; Feleke Moges
Journal:  BMC Public Health       Date:  2014-02-20       Impact factor: 3.295

8.  Epidemiology of multi-drug resistant organisms in a teaching hospital in oman: a one-year hospital-based study.

Authors:  Abdullah Balkhair; Yahya M Al-Farsi; Zakariya Al-Muharrmi; Raiya Al-Rashdi; Mansoor Al-Jabri; Fatma Neilson; Sara S Al-Adawi; Marah El-Beeli; Samir Al-Adawi
Journal:  ScientificWorldJournal       Date:  2014-01-14

9.  Prevalence and Antimicrobial Resistance of Enterococcus Species: A Retrospective Cohort Study in Italy.

Authors:  Mariarosaria Boccella; Biagio Santella; Pasquale Pagliano; Anna De Filippis; Vincenzo Casolaro; Massimiliano Galdiero; Anna Borrelli; Mario Capunzo; Giovanni Boccia; Gianluigi Franci
Journal:  Antibiotics (Basel)       Date:  2021-12-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.